drugset / Trial / NCT07822061

AMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose Weight

NCT07822061 ↗

Phase 3 Recruiting 400 enrolled Novo Nordisk A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people with excess body weight and to compare its effects with placebo. Participants will receive either NNC0487-0111, the treatment being tested, or placebo, a treatment with no active medicine. Which treatment participants receive is decided by chance. NNC0487-0111 is a new medicine that doctors cannot yet prescribe, but it has been tested in humans before.

Timeline

Start
2026-09-07
Primary completion
2029-02-05
Completion
2029-02-05

Drugs

EvaluationDrugModalityDoseRoute
Subject NNC0487-0111 Unknown — Subcutaneous

Indications